Jeffrey Dierks, Chief Commercial Officer at Harmony Biosciences Holdings, Inc. (HRMY), sold 20,000 shares at $33.30 ($672K) on 2021-09-01, disclosed to the SEC on 2021-09-03.
Open-market sale of $672k HRMY by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.30 | 6,698 | $223K | 33.2% |
| 2 | $33.30 | 6,698 | $223K | 33.2% |
| 3 | $34.26 | 3,302 | $113K | 16.8% |
| 4 | $34.26 | 3,302 | $113K | 16.8% |
| Total | $33.62 avg | 20,000 | $672K | 100% |
| Filing → |
| HRMY | SELL | 2025-01-21 | $2.3M | — | Filing → |
| HRMY | SELL | 2025-01-16 | $778K | — | Filing → |
| HRMY | SELL | 2025-01-15 | $532K | — | Filing → |